Richard Eastell

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial

Postmenopausal osteoporosis

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

The Use of Biochemical Markers of Bone Turnover in Osteoporosis